CRSP insiders were on both sides of the trade this year. Buys came to roughly $50,000 (one buyer), sales to $18.4 million (five sellers).
Patel Naimish (Executive Officer) made the biggest buy, worth around $50,000.
521 investment managers listed CRSP in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: 4 quarters in a row of net selling by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | KASINGER JAMES R. | Executive Officer | Sell | 1,990 | $60.04 | $119K | SEC |
| Sep 24, 2026 | KASINGER JAMES R. | Executive Officer | Sell | 10,400 | $60.24 | $626K | SEC |
| Sep 21, 2026 | Behbahani Ali | Director | Sell | 13,679 | $57.09 | $781K | SEC |
| Jun 1, 2026 | Patel Naimish | Executive Officer | Sell | 3,786 | $55.62 | $211K | SEC |
| Mar 24, 2026 | KASINGER JAMES R. | Executive Officer | Sell | 3,182 | $46.78 | $149K | SEC |
| Mar 24, 2026 | Kulkarni Samarth | CEO | Sell | 10,020 | $46.78 | $469K | SEC |
| Mar 24, 2026 | Prasad Raju | CFO | Sell | 3,708 | $46.78 | $173K | SEC |
| Mar 17, 2026 | Patel Naimish | Executive Officer | Sell | 3,150 | $48.26 | $152K | SEC |
| Mar 17, 2026 | Prasad Raju | CFO | Sell | 5,848 | $48.26 | $282K | SEC |
| Mar 17, 2026 | Prasad Raju | CFO | Sell | 4,021 | $48.26 | $194K | SEC |
| Mar 17, 2026 | KASINGER JAMES R. | Executive Officer | Sell | 3,450 | $48.26 | $166K | SEC |
| Mar 17, 2026 | Kulkarni Samarth | CEO | Sell | 10,349 | $48.26 | $499K | SEC |
| Mar 12, 2026 | KASINGER JAMES R. | Executive Officer | Sell | 2,800 | $52.80 | $148K | SEC |
| Mar 12, 2026 | Kulkarni Samarth | CEO | Sell | 9,798 | $52.80 | $517K | SEC |
| Feb 20, 2026 | Kulkarni Samarth | CEO | Sell | 6,967 | $52.58 | $366K | SEC |
In the last 12 months CRISPR Therapeutics AG insiders made open-market purchases worth about $50,000 and sales worth about $18.4 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CRSP was filed on 2026-10-08.
521 investment managers reported holding CRSP in SEC Form 13F filings for Q2 2026.
No congressional trades in CRSP were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).